Ifetroban
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Ifetroban, covering 2017-02-14 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension [Phase 2]